The American Heart Association will honor Annet Kirabo, D.V.M., Ph.D., FAHA, with the 2026 Joseph A. Vita Award at its Scientific Sessions 2026, to be held Nov. 6-9 in Chicago. Kirabo, a professor of medicine at Vanderbilt Health, is recognized for discoveries that revealed how immune activation and inflammation contribute to high blood pressure, fundamentally changing the understanding of hypertension's origins. The award, named after the late cardiovascular scientist Joseph A. Vita, M.D., founding editor of the Journal of the American Heart Association, is presented annually to a scientist whose research has significantly advanced cardiovascular biology or health within the past five years and has been published in the Association's journals.
Kirabo's groundbreaking work demonstrated that lipid oxidation-derived protein adducts act as neoantigens, triggering antigen-presenting cell activation, T-cell responses, vascular dysfunction, and hypertension. This paradigm shift opened new avenues for treating hypertension and related cardiovascular and kidney diseases. Manesh R. Patel, M.D., FAHA, the Association's 2026-2027 volunteer president, said, "Her pioneering discoveries represent a paradigm shift in cardiovascular biology, reshaping our understanding of hypertension by revealing how immune activation and inflammation drive cardiovascular disease." Patel also noted that Kirabo's identification of potential therapeutic targets, including reactive lipid molecules called isolevuglandins and sodium-sensing pathways in immune cells, has opened exciting possibilities for prevention and treatment.
The implications for patients and the medical community are profound. Hypertension affects nearly half of U.S. adults, and current treatments often fail to control blood pressure adequately. By uncovering the immune system's role, Kirabo's research suggests that immunomodulatory therapies could become a new class of antihypertensive drugs, potentially offering relief to millions who do not respond to existing medications. Her laboratory combines immunology, vascular biology, genomics, metabolomics, and single-cell technologies to identify new therapeutic strategies, spanning from fundamental mechanisms to translational research. With more than 230 scientific publications and sustained NIH funding, Kirabo's work continues to influence investigators worldwide, as evidenced by her roles on the editorial boards of Hypertension and Circulation Research.
Beyond her scientific achievements, Kirabo has been an active American Heart Association volunteer since 2009, serving on the Council on Hypertension Communications Committee and reviewing research proposals. Her dedication to mentorship has trained dozens of early-career investigators, many of whom have gone on to faculty positions, ensuring a lasting impact on cardiovascular research. "I am deeply honored to receive the Joseph A. Vita Award from the American Heart Association, an organization that has supported my career from my predoctoral and postdoctoral fellowships through my development as an independent investigator," Kirabo said. The award will be presented during the Opening Session on Saturday, Nov. 7. For more information about the American Heart Association's Scientific Sessions 2026, visit release link, and for heart health resources, see heart.org and stroke.org. The original release is available at www.newmediawire.com.
